LATEST ARTICLES
- Eli Lilly finds stigma is one of the worst parts of migraine as it aims to help break the taboo
- Game on, Pfizer: Merck’s Vaxneuvance boosts pneumococcal vaccine fight with coveted pediatric nod
- Florida man arrested in scheme to sell $230M in adulterated HIV meds to unsuspecting patients
- BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody’s
- GSK opens doors at $110M biologics smart factory in UK
